DK674387A - Proteaseinhibitorer - Google Patents
ProteaseinhibitorerInfo
- Publication number
- DK674387A DK674387A DK674387A DK674387A DK674387A DK 674387 A DK674387 A DK 674387A DK 674387 A DK674387 A DK 674387A DK 674387 A DK674387 A DK 674387A DK 674387 A DK674387 A DK 674387A
- Authority
- DK
- Denmark
- Prior art keywords
- protease inhibitors
- protease
- inhibitors
- Prior art date
Links
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 title 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US94673786A | 1986-12-22 | 1986-12-22 | |
| US07/127,282 US5055451A (en) | 1986-12-22 | 1987-12-07 | Aryloxy and arylacyloxy methyl ketones as thiol protease inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK674387D0 DK674387D0 (da) | 1987-12-21 |
| DK674387A true DK674387A (da) | 1988-06-23 |
Family
ID=26825501
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK674387A DK674387A (da) | 1986-12-22 | 1987-12-21 | Proteaseinhibitorer |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5055451A (da) |
| EP (1) | EP0272671B1 (da) |
| JP (1) | JPS63253061A (da) |
| AU (1) | AU602547B2 (da) |
| CA (1) | CA1329862C (da) |
| DE (1) | DE3789371T2 (da) |
| DK (1) | DK674387A (da) |
| ES (1) | ES2061480T3 (da) |
| IE (1) | IE62863B1 (da) |
| NZ (1) | NZ223002A (da) |
| ZA (1) | ZA879577B (da) |
Families Citing this family (64)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5874424A (en) * | 1995-12-20 | 1999-02-23 | Vertex Pharmaceuticals Incorporated | Inhibitors of interleukin-1β converting enzyme |
| US6008217A (en) * | 1995-12-20 | 1999-12-28 | Vertex Pharmaceuticals Incorporated | Inhibitors of interleukin-1β converting enzyme |
| US6204261B1 (en) * | 1995-12-20 | 2001-03-20 | Vertex Pharmaceuticals Incorporated | Inhibitors of interleukin-1β Converting enzyme inhibitors |
| US5003103A (en) * | 1989-11-20 | 1991-03-26 | Occidental Chemical Corporation | Preparation of 2-choloro-4,5-difluorobenzoic acid from 4,5-difluorophthalic anhydride of 4,5-difluorophthalic acid |
| US4937377A (en) * | 1989-11-20 | 1990-06-26 | Occidental Chemical Corporation | Preparation of 3,4-difluorobenzoic acid by the decarboxylation of 4,5-difluorophthalic anhydride or 4,5-difluorophthalic acid |
| US6995141B1 (en) | 1990-04-04 | 2006-02-07 | Vertex Pharmaceuticals Incorporated | Interleukin 1β protease and interleukin 1β protease inhibitors |
| US5444042A (en) * | 1990-12-28 | 1995-08-22 | Cortex Pharmaceuticals | Method of treatment of neurodegeneration with calpain inhibitors |
| CA2071674C (en) * | 1991-06-21 | 2003-08-19 | Kevin T. Chapman | Peptidyl derivatives as inhibitors of interleukin-1.beta. converting enzyme |
| JP3228347B2 (ja) * | 1991-06-25 | 2001-11-12 | 三菱化学株式会社 | シクロプロペノン誘導体 |
| JP3190431B2 (ja) * | 1991-07-01 | 2001-07-23 | 三菱化学株式会社 | ケトン誘導体 |
| US5204350A (en) * | 1991-08-09 | 1993-04-20 | Merck & Co., Inc. | Method of inhibiting osteoclast-mediated bone resorption by administration of n-heterocyclicalkyl-substituted phenyl derivatives |
| US5217994A (en) * | 1991-08-09 | 1993-06-08 | Merck & Co., Inc. | Method of inhibiting osteoclast-mediated bone resorption by administration of aminoalkyl-substituted phenyl derivatives |
| US6348570B1 (en) | 1991-08-16 | 2002-02-19 | Merck & Co., Inc. | Chromophore containing compounds and their use in determining interleukin-1β convertase activity |
| JPH05140063A (ja) * | 1991-11-19 | 1993-06-08 | Suntory Ltd | ジペプチド誘導体及びそれを有効成分とする骨疾患の予防及び治療剤 |
| CA2129976C (en) * | 1992-02-21 | 2002-09-17 | Kevin T. Chapman | Peptidyl derivatives as inhibitors of interleukin-1.beta. converting enzyme |
| US5317086A (en) * | 1992-03-09 | 1994-05-31 | The Regents Of The University Of California | Cysteine proteinase inhibitors and inhibitor precursors |
| US5374623A (en) * | 1992-08-20 | 1994-12-20 | Prototek, Inc. | Cysteine protease inhibitors effective for in vivo use |
| US5395958A (en) * | 1992-09-30 | 1995-03-07 | Mitsubishi Kasei Corporation | Cyclopropene derivatives |
| US5260478A (en) * | 1992-12-08 | 1993-11-09 | Sterling Winthrop Inc. | Iodinated aroyloxy carboxamides |
| ATE171171T1 (de) * | 1992-12-25 | 1998-10-15 | Mitsubishi Chem Corp | Alpha-aminoketon derivate |
| CA2111930A1 (en) * | 1992-12-25 | 1994-06-26 | Ryoichi Ando | Aminoketone derivatives |
| US5545672A (en) * | 1993-02-11 | 1996-08-13 | The University Of Texas System | Treatment of insulin resistance and type 2 diabetes mellitus with a thiol protease inhibitor |
| US5985838A (en) * | 1993-04-29 | 1999-11-16 | Vertex Pharmaceuticals, Inc. | Peptide analogs as irreversible interleukin-1β protease inhibitors |
| CA2122227A1 (en) * | 1993-04-29 | 1994-10-30 | Roland E. Dolle | Peptide analogs as irreversible interleukin-1.beta. protease inhibitors |
| US5462939A (en) * | 1993-05-07 | 1995-10-31 | Sterling Winthrop Inc. | Peptidic ketones as interleukin-1β-converting enzyme inhibitors |
| JPH0789951A (ja) * | 1993-06-03 | 1995-04-04 | Sterling Winthrop Inc | インターロイキン−１β転換酵素阻害剤 |
| US5843905A (en) * | 1993-06-04 | 1998-12-01 | Vertex Pharmaceuticals, Incorporated | Peptidic phosphinyloxymethyl ketones as interleukin-1β-converting enzyme inhibitors |
| ES2114654T3 (es) * | 1993-06-08 | 1998-06-01 | Vertex Pharma | Piridazinas como inhibidores de la enzima de conversion de la interleuquina-1beta. |
| US5866545A (en) * | 1993-08-13 | 1999-02-02 | Merck & Co., Inc. | Substituted ketone derivatives as inhibitors of interleukin-1β converting enzyme |
| US5486623A (en) * | 1993-12-08 | 1996-01-23 | Prototek, Inc. | Cysteine protease inhibitors containing heterocyclic leaving groups |
| US5714484A (en) * | 1993-12-08 | 1998-02-03 | Prototek, Inc. | α-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors |
| IL112759A0 (en) | 1994-02-25 | 1995-05-26 | Khepri Pharmaceuticals Inc | Novel cysteine protease inhibitors |
| US5716929A (en) * | 1994-06-17 | 1998-02-10 | Vertex Pharmaceuticals, Inc. | Inhibitors of interleukin-1β converting enzyme |
| US5847135A (en) * | 1994-06-17 | 1998-12-08 | Vertex Pharmaceuticals, Incorporated | Inhibitors of interleukin-1β converting enzyme |
| US5756466A (en) * | 1994-06-17 | 1998-05-26 | Vertex Pharmaceuticals, Inc. | Inhibitors of interleukin-1β converting enzyme |
| US6420522B1 (en) | 1995-06-05 | 2002-07-16 | Vertex Pharmaceuticals Incorporated | Inhibitors of interleukin-1β converting enzyme |
| US5574017A (en) * | 1994-07-05 | 1996-11-12 | Gutheil; William G. | Antibacterial agents |
| US5776718A (en) * | 1995-03-24 | 1998-07-07 | Arris Pharmaceutical Corporation | Reversible protease inhibitors |
| US5798442A (en) * | 1995-04-21 | 1998-08-25 | Merck Frosst Canada, Inc. | Peptidyl derivatives as inhibitors of pro-apoptotic cysteine proteinases |
| US5843904A (en) * | 1995-12-20 | 1998-12-01 | Vertex Pharmaceuticals, Inc. | Inhibitors of interleukin-1βconverting enzyme |
| WO1998001133A1 (en) * | 1996-07-08 | 1998-01-15 | Yamanouchi Pharmaceutical Co., Ltd. | Bone resorption inhibitors |
| JP2000517319A (ja) * | 1996-08-28 | 2000-12-26 | スミスクライン・ビーチャム・コーポレイション | システインプロテアーゼのインヒビター |
| US5942601A (en) * | 1997-11-21 | 1999-08-24 | The Reagents Of The University Of California | Peptide synthesis with sulfonyl protecting groups |
| WO1999046248A1 (en) | 1998-03-09 | 1999-09-16 | Vertex Pharmaceuticals Incorporated | 1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors |
| CA2324226C (en) | 1998-03-19 | 2012-06-05 | Vertex Pharmaceuticals Incorporated | Inhibitors of caspases |
| JP2003524603A (ja) * | 1998-10-06 | 2003-08-19 | スミスクライン・ビーチャム・コーポレイション | カスパーゼおよびアポトーシス |
| US6458760B1 (en) * | 1998-11-12 | 2002-10-01 | Henry Ford Health System | Method for treating tissue damaged from ischemia |
| JP2002537293A (ja) * | 1999-02-20 | 2002-11-05 | アストラゼネカ アクチボラグ | カテプシンｌおよび／またはカテプシンｓの阻害剤としてのアセタミドアセトニトリル誘導体 |
| US6506733B1 (en) | 1999-03-15 | 2003-01-14 | Axys Pharmaceuticals, Inc. | Compounds and compositions as protease inhibitors |
| PE20011350A1 (es) * | 2000-05-19 | 2002-01-15 | Vertex Pharma | PROFARMACO DE UN INHIBIDOR DE ENZIMA CONVERTIDORA DE INTERLEUCINA-1ß (ICE) |
| US7030116B2 (en) | 2000-12-22 | 2006-04-18 | Aventis Pharmaceuticals Inc. | Compounds and compositions as cathepsin inhibitors |
| JP2004523506A (ja) | 2000-12-22 | 2004-08-05 | アクシス・ファーマシューティカルズ・インコーポレイテッド | カテプシン阻害剤としての新規な化合物と組成物 |
| RS19504A (sr) | 2001-09-14 | 2007-02-05 | Aventis Pharmaceuticals Inc., | Nova jedinjenja i kompozicije kao inhibitori katepsina |
| HUP0401906A3 (en) | 2001-11-14 | 2008-07-28 | Aventis Pharma Inc | Novel cathepsin s inhibitors, process for their preparation and pharmaceutical compositions containing them |
| US7410956B2 (en) * | 2002-02-11 | 2008-08-12 | Vertex Pharmaceuticals Incorporated | Caspase inhibitor prodrugs |
| AU2005249503B2 (en) * | 2003-11-10 | 2011-08-25 | Vertex Pharmaceuticals Incorporated | ICE inhibitors for the treatment of autoinflammatory diseases |
| MX2007001337A (es) * | 2004-08-02 | 2008-03-13 | Genmedica Therapeutics Sl | Compuestos para inhibir amina-oxidasas que contienen cobre y usos de los mismos. |
| JP6490660B2 (ja) * | 2013-03-15 | 2019-03-27 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | 活性に基づくプローブの化合物、組成物、および使用方法 |
| ES2819218T3 (es) | 2014-10-06 | 2021-04-15 | Cortexyme Inc | Inhibidores de lisina gingipaína |
| WO2017083433A1 (en) | 2015-11-09 | 2017-05-18 | Cortexyme, Inc. | Inhibitors of arginine gingipain |
| KR102780603B1 (ko) | 2016-09-16 | 2025-03-12 | 라이트하우스 파마슈티컬스, 인코포레이티드 | 리신 진지파인의 케톤 억제제 |
| CA3033092C (en) | 2016-12-23 | 2023-12-19 | The Board Of Trustees Of The Leland Stanford Junior University | Activity-based probe compounds, compositions, and methods of use |
| KR102669535B1 (ko) | 2017-03-30 | 2024-05-24 | 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 | 생체 내 이미징을 위한 프로테아제 활성화 조영제 |
| US11708348B2 (en) | 2021-06-11 | 2023-07-25 | The Scripps Research Institute | Protease inhibitors for treatment of coronavirus infections |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4692552A (en) * | 1983-05-09 | 1987-09-08 | G. D. Searle & Co. | Protease inhibitors |
| US4539312A (en) * | 1984-07-11 | 1985-09-03 | E. R. Squibb & Sons, Inc. | Use of diamino ketones as analgesic agents |
| US4636492A (en) * | 1984-08-29 | 1987-01-13 | E. I. Du Pont De Nemours And Company | Inhibition of viral protease activity by peptide halomethyl ketones |
| US4652552A (en) * | 1984-09-10 | 1987-03-24 | E. I. Du Pont De Nemours And Company | Tetrapeptide methyl ketone inhibitors of viral proteases |
| ZA86746B (en) * | 1985-02-04 | 1986-09-24 | Merrell Dow Pharma | Novel peptidase inhibitors |
| US4820691A (en) * | 1987-06-24 | 1989-04-11 | E. R. Squibb & Sons, Inc. | Amino acid 1,2-diketo derivatives as renin inhibitors |
-
1987
- 1987-12-07 US US07/127,282 patent/US5055451A/en not_active Expired - Fee Related
- 1987-12-21 CA CA000554950A patent/CA1329862C/en not_active Expired - Fee Related
- 1987-12-21 JP JP62325156A patent/JPS63253061A/ja active Pending
- 1987-12-21 DE DE3789371T patent/DE3789371T2/de not_active Expired - Fee Related
- 1987-12-21 ES ES87118949T patent/ES2061480T3/es not_active Expired - Lifetime
- 1987-12-21 NZ NZ223002A patent/NZ223002A/en unknown
- 1987-12-21 AU AU82871/87A patent/AU602547B2/en not_active Ceased
- 1987-12-21 EP EP87118949A patent/EP0272671B1/en not_active Expired - Lifetime
- 1987-12-21 DK DK674387A patent/DK674387A/da not_active Application Discontinuation
- 1987-12-21 IE IE346787A patent/IE62863B1/en not_active IP Right Cessation
- 1987-12-21 ZA ZA879577A patent/ZA879577B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPS63253061A (ja) | 1988-10-20 |
| IE62863B1 (en) | 1995-03-08 |
| AU602547B2 (en) | 1990-10-18 |
| DK674387D0 (da) | 1987-12-21 |
| IE873467L (en) | 1988-06-22 |
| ES2061480T3 (es) | 1994-12-16 |
| CA1329862C (en) | 1994-05-24 |
| ZA879577B (en) | 1989-08-30 |
| EP0272671A2 (en) | 1988-06-29 |
| DE3789371D1 (de) | 1994-04-21 |
| EP0272671B1 (en) | 1994-03-16 |
| DE3789371T2 (de) | 1994-09-08 |
| US5055451A (en) | 1991-10-08 |
| EP0272671A3 (en) | 1990-06-13 |
| NZ223002A (en) | 1991-05-28 |
| AU8287187A (en) | 1988-07-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK674387D0 (da) | Proteaseinhibitorer | |
| DK51586D0 (da) | Peptidaseinhibitorer | |
| FI894747A7 (fi) | Uusia peptidaasi-inhibiittoreita | |
| FI900101A7 (fi) | Proteas-inhibitorer. | |
| DK478684D0 (da) | Enzyminhibitorer | |
| DE3785615D1 (de) | Hemmungsstoffe der serin-protease. | |
| DK140587D0 (da) | Selvhaerdende urethanklaebepasta | |
| DK149786A (da) | Proteolytisk enzym | |
| DK317287D0 (da) | Reduktase-inhibitorer | |
| PT84993A (fr) | Missil | |
| FI895962A7 (fi) | Proteaasi-inhibiittorit | |
| DE3674131D1 (de) | Substituierte dihalo-statin-reninhemmungsmittel. | |
| DK349586A (da) | Enzyminhibitor | |
| NO883955D0 (no) | Xx | |
| FI101796B1 (fi) | Uusia -glukosidaasi-inhibiittoreita | |
| NO875199L (no) | Renin-inhibitorer. | |
| FI906140A7 (fi) | Retroviraalisten proteaasien inhibiittoreita | |
| DK174087A (da) | Angiotensinkonverterende enzyminhibitor | |
| DK440887A (da) | Dopamin-beta-hydroxylase-inhibitorer | |
| NO860960L (no) | Avsetningsinhibitorer. | |
| NO875381D0 (no) | Renininhibitorer. | |
| DK69489D0 (da) | Aspartattranscarbamylase-inhibitorer | |
| NO872985L (no) | Inhibitor for polyuretanpropergoler. | |
| DK658489A (da) | Proteaseinhibitorer | |
| IS3397A7 (is) | Ensím (gerhvati) hindri (inhibitors) (Protease Inhibitors) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHB | Application shelved due to non-payment |